Symbols / LUCY Stock $1.08 +0.00% Lucyd, Inc

Healthcare • Medical Instruments & Supplies • United States • NCM
LUCY (Stock) Chart
About

Lucyd, Inc engages in the development and sale of smart eyeglasses and sunglasses in North America. Its flagship product is the Lucyd Lyte which enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform various smartphone tasks hands-free. It also provides Nautica Powered by Lucyd smart eyewear collection and various branded accessories, including a power brick, cleaning cloth, and a slipcase adorned; Eddie Bauer Powered by Lucyd smart eyewear collection; and Lucyd Armor line, an ANSI-certified smart safety glass for all-day wear. In addition, the company offers Lucyd app that provides unlimited voice ChatGPT interactions. It sells its products through Amazon, social selling, and retail stores, as well as through Lucyd.co, Walmart.com, Target.com, BestBuy.com, DicksSportingGoods.com, Brookstone.com, and eBay. The company was formerly known as Innovative Eyewear, Inc. and change its name to Lucyd, Inc in October 2025. Lucyd, Inc was founded in 2019 and is based in North Miami, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Instruments & Su Market Cap 6.80M
Enterprise Value 293.68K Income -7.59M Sales 2.66M
Book/sh 1.65 Cash/sh 1.03 Dividend Yield
Payout 0.00% Employees 13 IPO
P/E Forward P/E -2.40 PEG
P/S 2.56 P/B 0.65 P/C
EV/EBITDA -0.04 EV/Sales 0.11 Quick Ratio 6.68
Current Ratio 9.03 Debt/Eq LT Debt/Eq
EPS (ttm) -1.90 EPS next Y -0.45 EPS Growth
Revenue Growth 39.00% Earnings 2026-03-25 16:00 ROA -53.15%
ROE -83.60% ROIC Gross Margin 21.32%
Oper. Margin -260.39% Profit Margin -285.20% Shs Outstand 6.30M
Shs Float 5.66M Short Float 2.67% Short Ratio 1.49
Short Interest 52W High 5.56 52W Low 0.95
Beta 3.06 Avg Volume 354.66K Volume 15.26K
Target Price $3.00 Recom Buy Prev Close $1.08
Price $1.08 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.00
Mean price target
2. Current target
$1.08
Latest analyst target
3. DCF / Fair value
$-15.96
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.08
Low
$3.00
High
$3.00
Mean
$3.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-03-26 main Maxim Group Buy → Buy $1
2023-09-11 init Maxim Group — → Buy $2
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-21 GROSS HARRISON R Chief Executive Officer 1,500 $1.32 $1,980
2026-01-13 GAYLE OSWALD Chief Financial Officer 1,000 $1.66 $1,669
2026-01-08 DABROWSKI KONRAD Officer 1,300 $1.58 $2,054
2026-01-08 GROSS HARRISON R Chief Executive Officer 1,500 $1.60 $2,400
2025-12-18 GALKIN VLADIMIR Beneficial Owner of more than 10% of a Class of Security 12,966 $1.38 $17,893
2025-12-11 GALKIN VLADIMIR Beneficial Owner of more than 10% of a Class of Security 58,723 $1.49 $88,255
2025-10-10 GROSS HARRISON R Chief Executive Officer 8,967 $2.01 $23,786
2025-09-24 COHEN DAVID ERIC Chief Technology Officer 7,689 $2.04 $21,034
2025-09-23 GAYLE OSWALD Chief Financial Officer 8,935 $2.04 $29,436
2025-08-19 DABROWSKI KONRAD Officer 16,800 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2.66
+62.65%
1.64
+41.99%
1.15
+74.67%
0.66
Operating Revenue
2.66
+62.65%
1.64
+41.99%
1.15
+74.67%
0.66
Cost Of Revenue
2.09
+47.35%
1.42
+11.75%
1.27
+77.61%
0.72
Reconciled Cost Of Revenue
2.09
+47.35%
1.42
+11.75%
1.27
+77.61%
0.72
Gross Profit
0.57
+163.70%
0.22
+280.33%
-0.12
-111.99%
-0.06
Operating Expense
9.06
+11.35%
8.14
+20.82%
6.74
+22.02%
5.52
Research And Development
0.73
-11.47%
0.82
+23.74%
0.66
+26.20%
0.52
Selling General And Administration
8.20
+14.17%
7.18
+20.99%
5.93
+22.21%
4.86
Selling And Marketing Expense
2.97
+9.79%
2.71
+32.20%
2.05
-0.58%
2.06
General And Administrative Expense
5.23
+16.82%
4.47
+15.08%
3.89
+38.99%
2.80
Other Gand A
5.23
+16.82%
4.47
+15.08%
3.89
+38.99%
2.80
Other Operating Expenses
0.14
+0.00%
0.14
+0.00%
0.14
+0.00%
0.14
Total Expenses
11.16
+16.70%
9.56
+19.38%
8.01
+28.41%
6.24
Operating Income
-8.49
-7.21%
-7.92
-15.58%
-6.86
-22.93%
-5.58
EBITDA
-8.36
-7.53%
-7.77
-18.24%
-6.58
-18.60%
-5.54
Normalized EBITDA
-8.36
-7.53%
-7.77
-18.24%
-6.58
-18.60%
-5.54
Reconciled Depreciation
0.14
-9.40%
0.15
+75.22%
0.09
+161.79%
0.03
EBIT
-8.49
-7.21%
-7.92
-18.97%
-6.66
-19.43%
-5.58
Total Unusual Items
Total Unusual Items Excluding Goodwill
Special Income Charges
Write Off
Net Income
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Pretax Income
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Net Non Operating Interest Income Expense
0.00
+100.00%
-0.00
+97.11%
-0.11
Interest Expense Non Operating
0.00
-100.00%
0.00
-97.11%
0.11
Net Interest Income
0.00
+100.00%
-0.00
+97.11%
-0.11
Interest Expense
0.00
-100.00%
0.00
-97.11%
0.11
Other Income Expense
0.90
+474.97%
0.16
-19.45%
0.20
Other Non Operating Income Expenses
0.90
+474.97%
0.16
-19.45%
0.20
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Net Income From Continuing Operation Net Minority Interest
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Net Income From Continuing And Discontinued Operation
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Net Income Continuous Operations
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Normalized Income
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Net Income Common Stockholders
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Diluted EPS
-5.19
+52.25%
-10.87
+37.53%
-17.40
Basic EPS
-5.19
+52.25%
-10.87
+37.53%
-17.40
Basic Average Shares
1.50
+144.10%
0.61
+87.78%
0.33
Diluted Average Shares
1.50
+144.10%
0.61
+87.78%
0.33
Diluted NI Availto Com Stockholders
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Line Item Trend 2023-12-31
Total Assets
6.22
Current Assets
5.62
Cash Cash Equivalents And Short Term Investments
4.29
Cash And Cash Equivalents
4.29
Other Short Term Investments
Receivables
0.10
Accounts Receivable
0.09
Gross Accounts Receivable
0.12
Allowance For Doubtful Accounts Receivable
-0.03
Inventory
0.53
Prepaid Assets
0.64
Current Deferred Assets
Other Current Assets
0.06
Total Non Current Assets
0.60
Net PPE
0.15
Gross PPE
0.24
Accumulated Depreciation
-0.08
Machinery Furniture Equipment
0.11
Other Properties
0.13
Goodwill And Other Intangible Assets
0.37
Other Intangible Assets
0.37
Other Non Current Assets
0.07
Total Liabilities Net Minority Interest
0.66
Current Liabilities
0.62
Payables And Accrued Expenses
0.58
Payables
0.58
Accounts Payable
0.58
Current Debt And Capital Lease Obligation
Current Debt
Other Current Borrowings
Current Deferred Liabilities
0.04
Current Deferred Revenue
0.04
Total Non Current Liabilities Net Minority Interest
0.04
Non Current Deferred Liabilities
0.04
Non Current Deferred Revenue
0.04
Other Non Current Liabilities
Stockholders Equity
5.56
Common Stock Equity
5.56
Capital Stock
0.00
Common Stock
0.00
Share Issued
0.65
Ordinary Shares Number
0.65
Treasury Shares Number
0.00
Additional Paid In Capital
22.53
Retained Earnings
-16.97
Total Equity Gross Minority Interest
5.56
Total Capitalization
5.56
Working Capital
4.99
Invested Capital
5.56
Total Debt
Net Debt
Net Tangible Assets
5.18
Tangible Book Value
5.18
Duefrom Related Parties Current
0.01
Dueto Related Parties Current
0.00
Other Equity Interest
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-7.28
-7.95%
-6.74
-16.88%
-5.77
-78.83%
-3.22
Cash Flow From Continuing Operating Activities
-7.28
-7.95%
-6.74
-16.88%
-5.77
-78.83%
-3.22
Net Income From Continuing Operations
-7.59
+2.26%
-7.77
-16.55%
-6.66
-17.28%
-5.68
Depreciation Amortization Depletion
0.14
-9.40%
0.15
+75.22%
0.09
+161.79%
0.03
Depreciation
0.07
-39.00%
0.11
+79.22%
0.06
+176.43%
0.02
Amortization Cash Flow
0.07
+71.83%
0.04
+65.11%
0.02
+130.88%
0.01
Depreciation And Amortization
0.14
-9.40%
0.15
+75.22%
0.09
+161.79%
0.03
Amortization Of Intangibles
0.07
+71.83%
0.04
+65.11%
0.02
+130.88%
0.01
Other Non Cash Items
0.26
-8.11%
0.28
-6.73%
0.30
-71.65%
1.07
Stock Based Compensation
0.74
-4.73%
0.77
-17.29%
0.94
-36.44%
1.47
Provisionand Write Offof Assets
0.01
-59.75%
0.02
+234.87%
-0.01
-112.67%
0.12
Asset Impairment Charge
0.00
-100.00%
0.09
0.00
Operating Gains Losses
-0.13
-0.05
Gain Loss On Investment Securities
-0.13
-0.05
Change In Working Capital
-0.69
-141.84%
-0.29
+21.11%
-0.36
-57.64%
-0.23
Change In Receivables
-0.04
-705.45%
-0.00
-24.14%
-0.00
+97.99%
-0.18
Changes In Account Receivables
-0.04
-705.45%
-0.00
-24.14%
-0.00
+97.99%
-0.18
Change In Inventory
-0.91
-205.97%
-0.30
+47.10%
-0.56
-1281.43%
0.05
Change In Prepaid Assets
0.01
+117.54%
-0.08
+17.73%
-0.10
+27.63%
-0.14
Change In Payables And Accrued Expense
0.19
+109.94%
0.09
-69.92%
0.30
+346.34%
0.07
Change In Other Working Capital
0.07
+618.34%
0.01
+147.42%
0.00
+117.18%
-0.02
Change In Other Current Assets
-0.02
0.00
0.00
-100.00%
0.00
Investing Cash Flow
4.48
+186.71%
-5.16
-2497.27%
-0.20
+9.64%
-0.22
Cash Flow From Continuing Investing Activities
4.48
+186.71%
-5.16
-2497.27%
-0.20
+9.64%
-0.22
Net PPE Purchase And Sale
-0.07
-16.57%
-0.06
+18.70%
-0.08
+37.06%
-0.12
Purchase Of PPE
-0.07
-16.57%
-0.06
+20.72%
-0.08
+35.45%
-0.12
Sale Of PPE
0.00
-100.00%
0.00
0.00
Capital Expenditure
-0.25
+6.46%
-0.27
-6.15%
-0.25
-14.34%
-0.22
Capital Expenditure Reported
0.00
+100.00%
-0.04
Net Investment Purchase And Sale
5.03
+202.67%
-4.90
-9736.95%
0.05
0.00
Purchase Of Investment
-1.27
+73.97%
-4.90
-151.14%
-1.95
0.00
Sale Of Investment
6.30
0.00
-100.00%
2.00
0.00
Net Intangibles Purchase And Sale
-0.18
+13.45%
-0.20
-18.34%
-0.17
-184.99%
-0.06
Purchase Of Intangibles
-0.18
+13.45%
-0.20
-18.34%
-0.17
-184.99%
-0.06
Net Other Investing Changes
-0.30
Financing Cash Flow
6.68
-34.77%
10.24
+53.77%
6.66
-4.23%
6.96
Cash Flow From Continuing Financing Activities
6.68
-34.77%
10.24
+53.77%
6.66
-4.23%
6.96
Net Issuance Payments Of Debt
0.08
0.00
+100.00%
-0.11
-113.32%
0.82
Issuance Of Debt
0.12
0.00
0.00
-100.00%
1.48
Repayment Of Debt
-0.04
0.00
+100.00%
-0.11
+83.23%
-0.65
Long Term Debt Issuance
0.12
0.00
Long Term Debt Payments
-0.04
0.00
+100.00%
-0.11
+83.23%
-0.65
Net Long Term Debt Issuance
0.08
0.00
+100.00%
-0.11
+83.23%
-0.65
Short Term Debt Issuance
0.00
-100.00%
1.48
Short Term Debt Payments
-0.11
+83.23%
-0.65
Net Short Term Debt Issuance
0.00
-100.00%
1.48
Net Common Stock Issuance
1.23
-81.41%
6.61
+60.70%
4.12
-32.83%
6.13
Proceeds From Stock Option Exercised
5.64
+43.70%
3.93
+24.89%
3.15
0.00
Net Other Financing Charges
-0.27
+9.63%
-0.30
+39.02%
-0.49
-7433.38%
0.01
Changes In Cash
3.88
+334.08%
-1.66
-338.17%
0.70
-80.17%
3.51
Beginning Cash Position
2.63
-38.68%
4.29
+19.39%
3.59
+4404.26%
0.08
End Cash Position
6.51
+147.66%
2.63
-38.68%
4.29
+19.39%
3.59
Free Cash Flow
-7.53
-7.40%
-7.01
-16.43%
-6.02
-74.71%
-3.44
Common Stock Issuance
1.23
-81.41%
6.61
+60.70%
4.12
-32.83%
6.13
Issuance Of Capital Stock
1.23
-81.41%
6.61
+60.70%
4.12
-32.83%
6.13
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category